TITLE

treatment-naïve:

AUTHOR(S)
Huber, Jeffrey T.; Gillaspy, Mary L.
PUB. DATE
October 2000
SOURCE
Encyclopedic Dictionary of AIDS-Related Terminology;2000, p216
SOURCE TYPE
Book
DOC. TYPE
Reference Entry
ABSTRACT
A definition of the term "treatment-naïve" is presented. It refers to patients who have no history of having been treated for a specific condition with a particular drug. HIV-positive persons who have not been subjected to monotherapy have the best chance of driving their viral load to undetectable levels with a combination therapy.
ACCESSION #
23076724

 

Related Articles

  • Accrued HIV evidence turns treatment dogma on its head. Check, Erika // Nature;8/21/2003, Vol. 424 Issue 6951, p866 

    Focuses on the possible health risk posed by HIV drugs in patients. Inefficacy of drugs in subduing virus in HIV positive patients; Comments of various researchers on HIV therapy; Thoughts over the distribution of drugs among various developing countries.

  • First Case of Primary Multidrug-Resistant Pulmonary Tuberculosis in a HIV-Infected Patient in Hungary. Sárvári, C.; Szlávik, J.; Bánhegyi, D. // European Journal of Clinical Microbiology & Infectious Diseases;Oct2003, Vol. 22 Issue 10, p635 

    This article reports on the first case of primary multidrug-resistant pulmonary tuberculosis in a HIV-infected patient in Hungary. The risk factors for multidrug-resistant tuberculosis include: previous antituberculosis treatment or relapse; infection originating from a "hot spot" region; a...

  • Factors Affecting Adherence to Antiretroviral Therapy. Chesney, Margaret A. // Clinical Infectious Diseases;6/1/2000 Supplement 2, Vol. 30, pS171 

    Enumerates the factors that influence adherence to antiretroviral therapy for treating HIV infections. Patient factors; Medication regimen; Patient-health care provider relationship; System of care; Reasons reported by HIV-infected individuals for not taking their medications.

  • Taking Antiretroviral Therapy for HIV Infection. Laws, M. Barton; Wilson, Ira B.; Bowser, Diana M.; Kerr, Sarah E. // JGIM: Journal of General Internal Medicine;Dec2000, Vol. 15 Issue 12, p848 

    OBJECTIVE: To describe how people with HIV understand and experience the problem of adhering to antiretroviral medication regimens. DESIGN: We performed a qualitative study based on interviews with HIV-infected patients, including 46 clients of AIDS service organizations, who were sampled...

  • An audit of antiretroviral prescribing in HIV patients. Monteiro, Eric // International Journal of STD & AIDS;Oct1999, Vol. 10 Issue 10, p692 

    The article focuses on antiretroviral treatment in HIV-infected patients. Several antiretroviral treatments of different classes became available during the mid 1990s. Fundamental advances also occurred in the understanding of the pathogenesis of infection and therapeutic monitoring. Concensus...

  • treatment-experienced:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p216 

    A definition of the term "treatment-experienced" is presented. It refers to the patients with a history of having been treated for a specific condition with a particular drug. It has been shown that HIV monotherapy promotes the growth of treatment-resistant virus, thus many treatment-experienced...

  • HIV treatments -- the state of play. Maynard, Tony // HIV Australia;Jun-Aug2004, Vol. 3 Issue 4, p20 

    Traces the progress of HIV medication in Australia. Conditions of people living with HIV/AIDS diseases; Situations that call for the treatment of the disease; Classes of drugs formulated for the disease; Factors that contributed to the success of HIV medication.

  • Tipranavir cost effective in treatment-experienced HIV.  // PharmacoEconomics & Outcomes News;7/15/2006, Issue 507, p8 

    Discusses research being done on the cost effectiveness of tipranavir for treatment-experienced patients with HIV infections. Reference to a study by K. N. Simpson et al, published in the May to June 2006 issue of "Value in Health"; Range of the incremental cost-effectiveness ratio for...

  • Treatment Options for HIV-Associated Tuberculosis. Onyebujoh, Philip Chukwuka; Ribeiro, Isabela; Whalen, Christopher Curtis // Journal of Infectious Diseases;8/15/2007 Supplement, Vol. 196, pS35 

    The vicious interaction between the human immunodeficiency virus (HIV) infection and tuberculosis (TB) pandemics poses special challenges to national control programs and individual physicians. Although recommendations for the treatment of TB in HIV-infected patients do not significantly differ...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics